Collegium Pharmaceutical, Inc. Announces Second U.S. Patent Issued Covering DETERx(TM) Technology

CUMBERLAND, R.I.--(BUSINESS WIRE)--Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that a new patent has been issued by the U.S. Patent and Trademark Office (USPTO) relating to its tamper-resistant DETERx™ formulation platform. US Patent Number 7,771,707 contains claims that cover Collegium’s proprietary extended-release formulations, which are designed to resist dose dumping when subjected to a variety of physical methods of tampering.